Pharmaceutical - Daiichi Sankyo, Pricing

Filter

Current filters:

Daiichi SankyoPricing

Popular Filters

AstraZeneca’s blood thinner Brilinta/Brilique demonstrates cost effectiveness; new Nexium indication filed in Japan

24-10-2011

Data from eight countries shows that using Anglo-Swedish drug major AstraZeneca’s (LSE: AZN) Brilique/Brilinta…

AstraZenecaBrilintaBriliqueCardio-vascularDaiichi SankyoGastro-intestinalsNexiumPharmaceuticalPricingRegulation

Company Spotlight

ImmunoGen

ImmunoGen

Back to top